Articles 4, 5 and 6 of Implementing Regulation (EU) 2022/1646 specify the content of national risk-based plans and randomised surveillance plan focused on official controls on the use of pharmacologically active substances authorised as veterinary medicinal products or as feed additives and of prohibited or unauthorised pharmacologically active substances and residues thereof. These plans should contain, inter alia, the list of combinations of substances and species, products and matrices which are included in the control plans for which the rules for that selection are defined in this Delegated Regulation. Member States should include in their national plans also sampling strategy for which criteria mentioned in this Delegated Regulation should be taken into account.
Recital 7, Regulation (EU) 2022/1644
In forcesince 7 Jul 2022